Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.17 -0.12 (-9.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Other Accumulated Expenses (2014 - 2015)

Updated

Aldeyra Therapeutics (ALDX) recorded Other Accumulated Expenses of $48,657 in Q4 2015, down 0.4% from $48,839 a year earlier and down 60.3% from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Other Accumulated Expenses (2014 - 2015) Analysis & Trends

  • Across earlier years, Other Accumulated Expenses came in at $48,839 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aldeyra Therapeutics 70.58 Mn 70.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 48,657.00
Sep 30, 2015 122,664.00
Dec 31, 2014 48,839.00
API Access

Aldeyra Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALDX&period=max&api_key=YOUR_API_KEY